Login

ALBANY MOLECULAR RESEARCH INC SEC Filings

Filed On Filing
14 Feb 2018 AMENDMENT NO. 2
13 Feb 2018 AMENDMENT NO. 2 TO SCHEDULE 13G
22 Sep 2017 EFFECT
22 Sep 2017 EFFECT
22 Sep 2017 EFFECT
22 Sep 2017 EFFECT
22 Sep 2017 EFFECT
22 Sep 2017 EFFECT
22 Sep 2017 EFFECT
05 Sep 2017 SC 13D/A
05 Sep 2017 AMENDMENT NO. 1
05 Sep 2017 SC 13D/A
05 Sep 2017 AMENDMENT NO. 2
05 Sep 2017 AMENDMENT NO. 1
05 Sep 2017 Form 4: Fine Margalit, Executive Vice President, API

Received 12,318 shares as a grant or award · Returned 23,543 shares to the issuer ($512K) · Disposed of 21,725 Option to Purchase Common Stock (Disposition to Issuer) ($72.6K)

05 Sep 2017 Form 4: Ladin Felicia I, SVP, Treasurer & CFO

Received 4,993 shares as a grant or award · Returned 63,568 shares to the issuer ($1.38M) · Disposed of 172,478 Option to Purchase Common Stock (Disposition to Issuer) ($814K)

05 Sep 2017 Form 4: Hagen Steven R, SVP Manufacturing & Pharmaceut

Received 3,138 shares as a grant or award · Returned 43,655 shares to the issuer ($949K) · Disposed of 107,331 Option to Purchase Common Stock (Disposition to Issuer) ($845K)

05 Sep 2017 Form 4: Oconnor Kevin, Director

Returned 58,275 shares to the issuer ($1.27M) · Disposed of 92,347 Option to Purchase Common Stock (Disposition to Issuer) ($1.12M)

05 Sep 2017 Form 4: Napolitano Fernando, Director

Returned 3,802 shares to the issuer ($82.7K) · Disposed of 9,358 Option to Purchase Common Stock (Disposition to Issuer) ($31.3K)

05 Sep 2017 Form 4: Deming David H, Director

Returned 6,838 shares to the issuer ($149K) · Disposed of 9,358 Option to Purchase Common Stock (Disposition to Issuer) ($31.3K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support